Medifast (MED) Current Deferred Revenue (2018 - 2020)

Medifast has reported Current Deferred Revenue for 3 years, with the latest figure at $7.6 million in Q4 2020.

• For the quarter ending Q4 2020, Current Deferred Revenue rose 75.54% year-over-year to $7.6 million; the trailing twelve-month figure through Dec 2020 stood at $7.6 million (up 75.54% YoY), and the FY2020 full-year result was $7.6 million, up 75.54% from the prior year.
• Current Deferred Revenue for Q4 2020 stood at $7.6 million, up from $4.3 million in the prior quarter.
• The five-year high for Current Deferred Revenue was $7.6 million in Q4 2020, with the low at $2.8 million in Q4 2018.
• Historically, Current Deferred Revenue has averaged $4.9 million across 3 years, with a median of $4.3 million in 2019.
• Annual changes were most pronounced in 2019 — Current Deferred Revenue surged 54.92% — and 2020, when it surged 75.54%.
• Medifast's Current Deferred Revenue stood at $2.8 million in 2018, then surged by 54.92% to $4.3 million in 2019, then surged by 75.54% to $7.6 million in 2020.
• The last three Current Deferred Revenue figures came in at $7.6 million (Q4 2020), $4.3 million (Q4 2019), and $2.8 million (Q4 2018), per Business Quant data.